definiens: means any or all of thefollowing in any jurisdiction throughout the world : ( i ) patents, patent applications, provisional patent applications and similarinstruments ( including any and all substitutions, divisions, continuations, continuations - in - part, reissues, renewals, extensions, reexaminations, patents of addition, supplementary protection certificates, inventors ’ certificates, pediatric data packageexclusivity extensions, or the like ) ( collectively, ) ; ( ii ) trademarks, service marks, trade dress, trade names and Internetdomain names ( including all registrations or applications for any of the foregoing ), together with all goodwill associated witheach of the foregoing ( collectively, ) ; ( iii ) copyrights, copyright registrations, and copyright applications(collectively, ) ; ( iv ) trade secrets, know - how and other confidential and proprietary information, includingproduct specifications, manufacturing processes, batch records and other documentation outlining manufacturing processes, design of and modifications to machinery necessary for use in the manufacturing process, compounds, formulae, and inventions ( ) ; and ( v ) all other intellectual property or proprietary rights ( in each case whether or not subject to statutoryregistration or protection ) . For purposes of this Agreement, means ( A ) any and all methods, techniques, know - how, trade secrets, and other technologies ( including manufacturing methods, techniques, know - how, trade secrets, andother technologies ) for the noncovalent association of, or related to the association of, any agent ( such as a therapeutic ordiagnostic agent ) with one or more polymers such as carbohydrates or polypeptides ( including albumin ), ( B ) any productresulting therefrom, including any intermediate or the Product ( as defined in the CVR Agreement ), and ( C ) any methods ofusing such product ; means the Pharmaceutical Product comprising the chemical compound having a chemical nameof 5ß,20 - Epoxy-1,2a,4,7ß,10ß,13a - hexahydroxytax-11 - en-9 - one 4,10 - diacetate 2 - benzoate 13 - ester with ( 2R,3S)-N - benzoyl-3 - phenylisoserine known by the generic name and bound to albumin that is in the subject of the New DrugApplication No . 21 - 660 filed with the FDA and subject of the European Medicines Agency Marketing Authorization grantedon January 11, 2008, together with all amendments and supplements to such FDA and European Medicines Agency approvals(identified by the Company as ABRAXANE ) ; means all biological and drug candidates, compoundsor products being researched, developed, labeled, manufactured, tested, stored, used, sold, offered for sale, imported, andotherwise distributed or commercially exploited by the Company or any of its Subsidiaries ; and meansCOROXANE, nab - docetaxel ( ABI-008 ), nab - rapamycin ( ABI-009 ), nab-17AAG ( ABI-010 ), nab - thiocolchicine dimer ( ABI-011),and nab - novel taxane ( ABI 013 )